Integer to Present at 2024 Truist Securities MedTech Conference on June 18
PLANO, Texas, June 06, 2024 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development […]
TRILLION ENERGY ANNOUNCES INCREASE OF NON-BROKERED PRIVATE PLACEMENT AND FIRST AND SECOND TRANCHE CLOSINGS
Vancouver, B.C. , June 06, 2024 (GLOBE NEWSWIRE) — Trillion Energy International Inc. (“Trillion” or the “Company“) (CSE: TCF) (OTCQB: […]
Toll Brothers Announces New Luxury Home Community Coming Soon to Popular West Midtown in Atlanta
ATLANTA, June 06, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, today […]
Ethan Allen Announces Plans to Open New Design Centers in Albuquerque, Louisville, and Watchung
DANBURY, Conn., June 06, 2024 (GLOBE NEWSWIRE) — Ethan Allen has announced plans to move its Albuquerque, New Mexico, and […]
Dogfish Head & Dan-O’s Seasoning to Debut Limited-Edition Grilling Kit
MILTON, Del., June 06, 2024 (GLOBE NEWSWIRE) — Just in time for the official start of summer, Dogfish Head and […]
TOMI Environmental Solutions, Inc. Announces Cost Reduction Efforts to Sustain Long Term Growth and Achieve Profitability
Company restructures executive compensation and reduces external consulting fees Expects to reduce cash used in operations by 30% (Approximately $500,000) […]
Proton Capital Announces Completion of Qualifying Transaction and Closing of First Tranche of Public Offering
REGINA, Saskatchewan, June 06, 2024 (GLOBE NEWSWIRE) — PROTON CAPITAL CORP. (“Proton” or the “Corporation”) (PTN.P-TSX-V), is pleased to announce […]
Le CN propose officiellement l’arbitrage exécutoire à la CFTC
MONTRÉAL, 06 juin 2024 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) a annoncé aujourd’hui qu’il avait officiellement proposé […]
CN Formally Offers Binding Arbitration to TCRC
MONTREAL, June 06, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) today announced that earlier this week, it had […]
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
– Final positive CORE-001 safety and efficacy findings were published simultaneously online by Nature Medicine and featured at ASCO 2024 – […]
